Posts by: Ana Pena

News

MG-ADL, a patient-reported scale commonly used to address symptom severity in myasthenia gravis (MG), has a poor sensitivity for measuring generalized muscle weakness. Researchers suggest that more questions about ... Read more

January 3, 2019January 3, 2019

Common Clinical Scales Insufficient to Evaluate Swallowing Problems in MG Patients, Study Reports

News

Commonly used clinical scales to measure symptom severity in myasthenia gravis (MG) patients are insufficient to precisely evaluate swallowing problems and predict the risk of silent aspiration, a study ... Read more

October 18, 2018October 18, 2018

Gut Microbiota Differs in Myasthenia Gravis Patients, Pilot Study Reports

News

Gut microbiota is altered in people with myasthenia gravis (MG), opening the door for exploring the use of microbiota-modulating therapies, like probiotics, as potential ways of better managing the disease. ... Read more

October 11, 2018October 11, 2018

Walk Tests a Reliable Measure of Exercise Capacity in MG Patients, Study Suggests

News

Two timed walk tests were found to be highly reliable for the measurement of exercise capacity in patients with mild to moderate generalized myasthenia gravis (MG), a study reports. The ... Read more

September 21, 2018September 21, 2018

Thymus Tumor Elevates Risk of Ocular MG Becoming Generalized, Case Series Finds

News

Thymoma, a tumor of the thymus gland that can be benign or malignant, elevates ocular myasthenia gravis (MG) patients’ risk of developing a generalized form of the disease, a ... Read more

September 13, 2018September 13, 2018

Robot-assisted Thymectomy Considered Safe for MG Patients, Singapore Study Says

News

Robot-assisted surgery to remove the thymus gland is considered a safe method of performing a thymectomy on myasthenia gravis patients, a recent study in Singapore shows. The study, “Robotic Thymectomy in Patients ... Read more

July 17, 2018July 17, 2018

Multidisciplinary Support Is Key to Managing Pregnancy in Myasthenia Gravis, Case Report Highlights

News

Early support from a diverse team of clinicians is key to successfully managing pregnancy in women with myasthenia gravis, particularly if a pregnancy is complicated by pre-eclampsia, a case ... Read more

May 29, 2018May 29, 2018

Rituxan Improves Muscle Strength, Allows Refractory MG Patients to Reduce Steroids, Study Says

News

Treatment with Rituxan (rituximab) provided sustained clinical improvement, increased muscle strength, and extended the time before disease worsening in myasthenia gravis, according to researchers. It also allows myasthenia gravis (MG) patients ... Read more

May 15, 2018May 15, 2018

Genetic Variants, Other Medications Influence Optimal Dose of Prograf in MG Patients, Study Suggests

News

The therapeutic effects of Prograf (tacrolimus) in myasthenia gravis (MG) patients are influenced not only by dosage, but also by patients’ genetic profiles and other medications they may be taking for the ... Read more

March 6, 2018

Refractory Myasthenia Gravis Increases Risk for Crises, Hospitalizations, Researchers Report

News

People with refractory myasthenia gravis are at a higher risk of myasthenic crises and of being hospitalized compared to non-refractory patients, researchers report. Results reveal an increased disease burden ... Read more

Posts by: Ana Pena

Ana Pena

MG-ADL Symptom Scale Would Benefit from Questions on Generalized Weakness, Study Says

Common Clinical Scales Insufficient to Evaluate Swallowing Problems in MG Patients, Study Reports

Gut Microbiota Differs in Myasthenia Gravis Patients, Pilot Study Reports

Walk Tests a Reliable Measure of Exercise Capacity in MG Patients, Study Suggests

Thymus Tumor Elevates Risk of Ocular MG Becoming Generalized, Case Series Finds

Robot-assisted Thymectomy Considered Safe for MG Patients, Singapore Study Says

Multidisciplinary Support Is Key to Managing Pregnancy in Myasthenia Gravis, Case Report Highlights

Rituxan Improves Muscle Strength, Allows Refractory MG Patients to Reduce Steroids, Study Says

Genetic Variants, Other Medications Influence Optimal Dose of Prograf in MG Patients, Study Suggests

Refractory Myasthenia Gravis Increases Risk for Crises, Hospitalizations, Researchers Report

Pin It on Pinterest